Aromatase inhibitors and mood disturbances

Keyphrases

• Aromatase Inhibitors 100%
• Mood Disturbance 100%
• Anastrozole 50%
• Selective Estrogen Receptor Modulators 33%
• Hot Flashes 33%
• Adjuvant Therapy 16%
• Cardiovascular Risk 16%
• Treatment Strategy 16%
• Mechanism of Action 16%
• Low Incidence 16%
• Postmenopausal Women 16%
• Treatment Discontinuation 16%
• Older Women 16%
• Negative Effects 16%
• Lipid Metabolism 16%
• Memory Impairment 16%
• Early Breast Cancer 16%
• Hormone Receptor-positive 16%
• Venous Thromboembolic Events 16%
• Extended Use 16%
• Specific Mechanisms 16%
• Arthralgia 16%
• Hormone Receptor-positive Breast Cancer 16%
• Somnolence 16%
• Bone Mineral Density 16%
• Psychiatric History 16%
• Vaginal Bleeding 16%
• Third Generation 16%
• Exemestane 16%
• Mood Changes 16%
• Myalgia 16%
• Estrogen Hormone 16%
• Letrozole 16%
• Endometrial Intraepithelial Neoplasia 16%
• Gynaecological Symptoms 16%
• Raloxifen 16%
• Sequential Approach 16%

Medicine and Dentistry

• Mood Disorder 100%
• Aromatase Inhibitor 100%
• Tamoxifen 66%
• Anastrozole 50%
• Breast Cancer 33%
• Selective Estrogen Receptor Modulator 33%
• Hot Flush 33%
• Arthralgia 16%
• Adjuvant Therapy 16%
• Neoplasm 16%
• Postmenopause 16%
• Cardiovascular Risk 16%
• Thromboembolism 16%
• Lipid Metabolism 16%
• Hormone Receptor 16%
• Somnolence 16%
• Bone Density 16%
• Vagina Bleeding 16%
• Memory Disorder 16%
• Psychiatric History 16%
• Exemestane 16%
• Myalgia 16%
• Letrozole 16%
• Mood Change 16%
• Side Effect 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Mood Disorder 100%
• Aromatase Inhibitor 100%
• Tamoxifen 66%
• Anastrozole 50%
• Breast Cancer 33%
• Hot Flush 33%
• Selective Estrogen Receptor Modulator 33%
• Arthralgia 16%
• Neoplasm 16%
• Cardiovascular Risk 16%
• Thromboembolism 16%
• Hormone Receptor 16%
• Somnolence 16%
• Memory Disorder 16%
• Exemestane 16%
• Vagina Bleeding 16%
• Myalgia 16%
• Letrozole 16%
• Side Effect 16%